Clinical Trial Update: Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical study sponsored by NIAID evaluating protective strategies for household contacts exposed to newly diagnosed multidrug-resistant tuberculosis pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis, MDR | Phase 3 | Status: ACTIVE_NOT_RECRUITING